Establishes pharmacist licensing exemption for certain dialysis-related drugs and devices.
Received in the Senate Referred to SCM
Email me when A 2001 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 2001. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill lets drug makers and wholesale distributors sell and deliver dialysate drugs and devices for home dialysis without a pharmacy license, provided they follow strict safety and delivery rules. It affects patients with end‑stage renal disease, their caregivers, physicians, and requires a consultant pharmacist to perform weekly quality checks.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 2001
3 free questions a day, no accountHearings
- General Assembly — SessionGeneral Assembly · Sep 24, 2026
- Health — MeetingHealth · Jun 18, 2026
- Regulated Professions — MeetingRegulated Professions · Feb 12, 2026
History
- Reported and Referred to Assembly Oversight, Reform and Federal Relations Committee
- Introduced, Referred to Assembly Regulated Professions Committee
Sponsors
- Annette Quijano (D) · sponsor
- Guardian, Donald A.
- Quijano, Annette
- Scharfenberger, Gerry
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 2001 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 2001 freeOr ask your AI assistant about A 2001 directly:
Add to Claude, ChatGPT or Cursor